MedTrace Logo

Volumetric Magnetic Resonance Imaging in Dementia

NCT05119114 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-11-12

No results posted yet for this study

Summary

Dementia is a term for the impaired ability to remember, think, or make decisions that interferes with doing everyday activities. Alzheimer's disease is the most common type of dementia. Though dementia mostly affects older adults, it is not a part of normal aging. This study aims to assess the role of volumetric MRI in evaluation of different types of dementia.

Conditions

Interventions

DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

A standardized multi-parametric MRI protocol will be implemented for all patients. All sequences will be acquired on a 1.5 Tesla scanner. After completion of the MRI study, the digital imaging and communication data will be sent to a diagnostic workstation for post-processing and analysis. Patients of the study will be subjected to detailed structural MRI for detection of signs of neurodegenerative changes. Volumetric high-resolution 3D scans will be used for quantitative study.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hosam A Youssif, MD · Assiut University

  • Ahmed Abdel-Razzak, McS · Assiut University

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05119114 on ClinicalTrials.gov